TPO and COVID-19: TPO can trigger megakaryocytes (MKs) to express Von Willebrand factor (vWF), which is upregulated during periods of stress such as inflammation due to COVID‐19 [12]; then increased vWF stimulates MKs to produce PLTs through glycoprotein (GP)Ib/vWF [13].